News and blogs
404 results found.
Blood Cancer UK's strategy
Read Blood Cancer UK's update on our organisational strategy.
We're funding 13 new research projects
Find out more about the latest blood cancer research projects that will receive £3 million pounds of funding from Blood Cancer UK
Our audiences: who should we be talking to?
As part of Blood Cancer UK's new organisational strategy, we looked at how we can define and develop our audiences so we can work towards our vision of beating blood cancer.
What happens if I have blood cancer and test positive for covid?
We talked to six people with blood cancer about their experience of accessing new antiviral and antibody treatments after they tested positive for covid.
COVID-19 booster jabs and blood cancer
New data reveals just 45% of immunocompromised people in England have had a booster dose of the Covid vaccine.
I can’t be a cancer patient. I am a mother!
Emily was diagnosed with blood cancer when her daughter was just 18 months old. Here, she reflects on the emotional impact of facing cancer as a mother. Eight years on, Emily is 'officially cured' and is enjoying precious time with her daughter.
Find out more about the Covid antibody treatment Evusheld
The treatment consists of two long-acting antibodies called tixagevumab and cilgavimab.
What do we mean when we talk about beating blood cancer?
Our Chief Executive, Gemma Peters, is writing to update you on our organisational strategy. With the help of our community, we first looked at what we mean by beating blood cancer, and came up with an initial draft of a vision statement.
Our response to Evusheld – a treatment to prevent Covid for the immunosuppressed
While we welcome the news of a new Covid treatment for immunosuppressed people – called Evusheld – we call for the Government to urgently set out its approach on how it will use preventative treatments for them.
Why are people with blood cancer invited for a 5th vaccine dose (second booster)?
People with blood cancer are now being offered a second covid vaccine booster (a 5th vaccine dose). Here's why.
I've got leukaemia and caught Covid two weeks ago
Stephen Pollard, Editor at large for the Jewish Chronicle, lives with chronic lymphocytic leukaemia and has spent the last couple of years trying to avoid Covid. But two weeks ago, he tested positive. We asked him to write about his experience.
Shaun Leane opens his heart to us for Mother's Day
Today we're thrilled to announce our collaboration with eminent jewellery designer Shaun Leane, who will donate 10% of retail sales of his renowned Hook Heart bracelet towards blood cancer research.
Pandemic may have long-lasting impact on blood cancer survival, warn MPs
MPs raise concern about pandemic on cancer care.
How our blood cancer and Covid survey has led to change
We’re writing this to update you on what our recent survey on blood cancer and Covid found, what has happened since, and the impact it made.
“If you’re struggling to see the light, I want you to know that things do get better”
Charlotte was diagnosed with Hodgkin lymphoma at 23 years old. Here, she talks about the difficulties of getting a diagnosis, the side effects of treatment and what inspired her to launch a line of gifts and accessories in aid of Blood Cancer UK.
The headline results from our survey ‘How can we beat blood cancer in this generation?’
Blood Cancer UK and ITN Productions Industry News
Blood Cancer UK are co-producing a programme with ITN Productions Industry News to raise awareness of blood cancer.
Blood Cancer UK asks: How can we be the generation that beats blood cancer?
Blood Cancer UK's Chief Executive, Gemma Peters, wants to know how the charity can best meet the needs of people with blood cancer, and asks that they fill in the charity's latest survey.
Racial inequalities in COVID-19 vaccine doses
Research shows that white British people receiving the third COVID-19 vaccine dose is almost double that of some ethnic minorities.
Latest updates from the Covid-19 Vaccine Research Collaborative
Find out the latest information on the Covid-19 Vaccine Research Collaborative from Blood Cancer UK.
